Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms

preview_player
Показать описание
NIA OSBR has issued a new, time-sensitive funding opportunity for small businesses working on novel therapeutics targeting fundamental mechanisms of aging (RFA-AG-21-026). This pre-application webinar provides an overview of the SBIR U44 funding announcement and discuss NIA’s critical focus areas and research priorities designed for the U44.

Date: August 27, 2020
Speakers: Todd Haim Ph.D., Chief, NIA OSBR; Chhanda Dutta, Ph.D., Chief, Clinical Gerontology Branch, NIA Division of Geriatrics and Clinical Gerontology; Rebecca Fuldner, Ph.D., Health Scientist Administrator, NIA Division of Aging Biology

  1. National Institute on Aging
  2. Small Business Research
  3. Small Business Grants
  4. Small Business Funding
  5. Startup Funding
  6. SBIR
Рекомендации по теме
Preclinical Development of 1:11:25

Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (with Audio Descriptions)

Preclinical Development of 1:08:28

Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms

NACFC 2022 | 1:59:13

NACFC 2022 | S21: Preclinical Assessment of Novel Genetic Therapies

Preclinical evaluation of 0:27:15

Preclinical evaluation of novel OT-analogs for the potential treatment of social behavioral deficits

Preclinical Evaluation of 0:48:20

Preclinical Evaluation of CAR T Immunotherapies Using Novel Animal Models [Webinar]

Stem Cell Clinical 0:47:00

Stem Cell Clinical Trials: Designing Preclinical Studies for First in Human Trials | Joy Cavagnaro

The Resistant Cancer 0:40:49

The Resistant Cancer Cell Line Collection as Preclinical Models of Acquired Resistance Formation

FUTEX2021－Conference：Preclinical development of 0:08:33

FUTEX2021－Conference：Preclinical development of a novel anticancer agent

Clinical Trial Regulations 0:19:17

Clinical Trial Regulations for Clinical Development of Traditional Medicines

Overcoming pre-clinical challenges 0:03:19

Overcoming pre-clinical challenges in novel cell therapy research and development

ProsTIC24 - Benjamin 0:10:03

ProsTIC24 - Benjamin Blyth: Advances in Preclinical Theranostic Discovery

Preclinical Development: Early 0:27:06

Preclinical Development: Early Considerations for Different Molecule Types -Tina Rogers

Novel Approaches to 0:05:50

Novel Approaches to Hemophilia Gene Therapy in Preclinical Development

Zebrafish Models of 0:20:18

Zebrafish Models of TANGO2 deficiency for preclinical studies of TANGO2 Deficiency Disorder

JK06, a biparatopic 0:01:15

JK06, a biparatopic ADC in preclinical development

[Webinar] Preclinical Evaluation 0:58:54

[Webinar] Preclinical Evaluation of CAR-T Immunotherapies Using Novel Animal Models (20220628）

Multimodal Preclinical Cancer 0:46:05

Multimodal Preclinical Cancer Imaging: Approaches and Novel Theranostics

Preclinical evaluation of 0:30:05

Preclinical evaluation of Marine Natural Products for Neuroscience Drug Discovery

From preclinical to 0:28:04

From preclinical to clinical: Making drug development efficient thru community-based collaboration

Drug Discovery and 0:07:50

Drug Discovery and Development - Overview | New Drug Discovery Procedure | Science Land

Drug discovery and 0:07:22

Drug discovery and development process

Download Day 2024 0:35:31

Download Day 2024 — Preclinical at Recursion (Laura Schaevitz, SVP and Head of Research)

[49] Targeting EGFR: 0:02:17

[49] Targeting EGFR: integration of novel therapeutics in the management of H&N cancer

Preclinical Modeling & 0:49:24

Preclinical Modeling & Therapeutics Core: Updates & Opportunities